How to Assess Donor Liver Biopsies (modified from UCSF LW Browne and L Ferrell)

Slides:



Advertisements
Similar presentations
Chapter 20 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Advertisements

Neonatal Liver Biopsy Dr Claire Bowen Consultant Paediatric Pathologist.
Significance of the total i-score
ENVR 430 Hepatic Physiology and Toxicology Nov 17, 2006 Jane Ellen Simmons,
NORMAL LIVER Bile duct Hepatic arteriole Portal vein.
"With ordinary talent and extraordinary perseverance, all things are attainable." - Thomas E. Buxton "Achievement is connected with action, not in genes..…!”
F ATTY L IVER Shahin Merat, M.D. Associate Professor of Medicine Digestive Disease Research Center, Tehran University of Medical Sciences, 8 th International.
Skin: Neurofibromatosis Lab 5, Case 1. Neurofibromas Some lesions can be seen as subcutaneous swellings (arrow) and others form pedunculated masses. Most.
Pathology of Chronic Viral Hepatitis: Nomenclature Grade & Stage Carmen Gonzalez Keelan MD FCAP FASCP Consultant, UPR School of Medicine.
بسم الله الرحمن الرحيم Noushin Afshar Moghaddam, M.D
Liver Pathology, CASE 2 53 year-old with chronic alcohol and drug abuse who has been in numerous rehabilitation facilities in the past now presents with.
IL FEGATO IL PANCREAS…..ed I loro segnali
Liver and pancreas SYLLABUS: RBP(Robbins Basic Pathology) Chapters: The Liver and the Biliary Tract The Pancreas.
Chapter 20 PART IV: Molecular Pathology of Human Disease Molecular Basis of Liver Disease Companion site for Molecular Pathology Author: William B. Coleman.
Evaluation of Liver Histology in Clinical Trials for Chronic Viral Hepatitis Zachary Goodman, M.D., Ph.D. Chief, Hepatic Pathology Armed Forces Institute.
Hepatobiliary system Integrated practical
Reversible cell injury  cellular swelling (Hydropic changes)  Fatty changes Irreversible cell injury  Necrosis  Apoptosis Cell Injury.
Integrated practical Dr Shaesta Naseem
Glycogenic Hepatopathy An Underrecognized Hepatic Complication of Diabetes Mellitus Michael Torbenson, MD,* Yunn-Yi Chen, MD, PhD,w Elizabeth Brunt, MD,z.
Hepatobiliary system Pathology Dept, KSU GIT Block.
Alcoholic liver disease
Acute viral hepatitis There is disruption of lobular architecture, inflammatory cells in the portal tracts & sinusoids, and hepatocellular apoptosis (arrow).
Date of download: 7/3/2016 From: Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes Ann Intern Med. 2000;133(4): doi: /
Alcohol related Liver Disease
Practical 1 Fatty change 28/2/2016. Contents Slide: Fatty change- liver Jar: Fatty liver Case 1 discussion.
Pasi Erkkilä and Akseli Koskela
Patterns of Hepatic Injury
Liver cirrhosis.
Part I: Liver function in oncology: biochemistry and beyond
Fatty Liver: Imaging Patterns and Pitfalls
High dietary salt decreases antioxidant defenses in the liver of fructose-fed insulin- resistant rats  Waleska Claudia Dornas, Wanderson Geraldo de Lima,
Abnormal intracellular accumulations: (A) Fatty change in liver (alcoholic steatosis): Tissue processed for H&E staining (lipid extracted). (Inset): Frozen.
BY: Asmaa Alastal. wafaa hanouna. Salma abu taha. .Sara shaban
Hepatic Disease Associated with Pregnancy
From: Orbital Volume Augmentation After Injection of Human Orbital Adipose-Derived Stem Cells in Rabbits Invest. Ophthalmol. Vis. Sci ;54(4):
Digestive pathology 2.
Chronic viral hepatitis type B with “ground glass” cells
Chapter 12 Liver Transplantation 1
Alcoholic cirrhosis and acute alcoholic fatty liver with cholestasis
Non-alcoholic steatohepatitis with positive ANA
Chapter 12 Liver Transplantation 1
Orthotopic liver transplant, recurrent non-alcoholic steatohepatitis
Toxic responses of the liver
More Than Meets the Eye: Identifying Who Is at Risk for NASH
Alcoholic foamy degeneration with early alcoholic cirrhosis
Acute hepatitis induced by greater celandine (Chelidonium majus)
Kester Crosse, Onuora G. Umeadi, Frank A
Chronic viral hepatitis type B and chronic delta
Chapter 3 Fatty Liver Diseases 1 Alcoholic steatosis Case 3.1.
Non-invasive diagnosis of non-alcoholic fatty liver disease
Volume 133, Issue 1, Pages (July 2007)
Omega-3 fatty acids decreases oxidative stress, tumor necrosis factor-alpha, and interleukin-1 beta in hyperthyroidism-induced hepatic dysfunction rat.
Volume 149, Issue 2, Pages (August 2015)
Volume 128, Issue 7, Pages (June 2005)
Volume 137, Issue 2, Pages (August 2009)
Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis  William R Kessler, Oscar W Cummings, George Eckert, Naga Chalasani,
What is the long-term outcome of the liver allograft?
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Volume 141, Issue 5, Pages e9 (November 2011)
Volume 39, Issue 4, Pages (October 2003)
Volume 44, Issue 4, Pages (April 2006)
Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal Disease  Ferga C. Gleeson, Amy C. Clayton, Lizhi Zhang,
Mallory–Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C  Mina O. Rakoski, Morton B. Brown, Robert.
Volume 150, Issue 3, Pages (March 2016)
Volume 64, Issue 6, Pages (June 2016)
Cell Injury Lab Dr Mamlook Elmagraby
Toxic responses of the liver
Volume 131, Issue 5, Pages (November 2006)
Results of Living Donor Age of Sixth Decade for Adult Liver Transplantation Using a Right Lobe graft Seok-Hwan Kim.
Top left—haematoxylin van Gieson (HvG) stain showing mild zone 3 steatosis without fibrosis, in which collagen fibres (pink–red, arrow) are confined to.
Presentation transcript:

How to Assess Donor Liver Biopsies (modified from UCSF LW Browne and L Ferrell)

Learn the Fat Terminology Macrovesicular fat: TWO types –Large droplet (old term macrovesicular) –Small droplet (old term microvesicular) Microvesicular: VERY small droplets filling hepatocytes, very rare and not easily seen on H&E (EM)

Macrovesicular or Large Droplet Fat is defined as a fat droplet(s) occupying greater than one-half of the hepatocyte.

Small Droplet Fat is defined as a fat droplet(s) occupying less than one-half of the hepatocyte and not displacing nuclei (This is a form of macrovesicular fat but is not as bad as large droplet fat for graft outcome.)

“True” microvesicular steatosis is reserved for very small, uniform fat globules packed within hepatocytes, visible at least as patches at 10X, as is seen, for example, in fatty liver of pregnancy. Trichrome

Large Droplet Fat Volume The overall volume of large droplet fat occupying the total liver biopsy should be estimated (For example, at 10x, just look to see about what % of the liver parenchyma has large droplet fat, do not include portal zones/scar.) This is the key factor for estimating usability of the graft

>50% large droplet

10-15% large droplet

Less than 5% large droplet; gylcogenated nuclei, don’t confuse with fat

Small Droplet Fat The percentage of the total cells affected by small droplet fatty change should be estimated. –The total volume of large droplet volume and of small droplet fatty change % cells together should not exceed 100%. Small and large droplet is frequently seen together in the same cells. This total may be used to determine graft usage in borderline cases. Note: On the old form, microvesicular fat was used as the term for this small droplet fat

20-30% large droplet steatosis; >60% small droplet steatosis

Determining the Presence of “True” Microvesicular Fat “True” microvesicular steatosis can be very difficult to impossible to appreciate on frozen sections. –However, it is very uncommon in donor liver biopsies, and it is highly unlikely that you will really see it so think again if you’re tempted to make this diagnosis. –One can see “tiny bubble artifact” in hepatocyte cytoplasm, not to be confused with true microvesicular fat.

Important Fat Amounts Large droplet fat: <30%: Team will probably use graft 30-50%: May or may not use graft >50%: Would discard graft Small droplet fat may become important in the borderline cases

Fibrosis and Inflammation Can be estimated for form Make sure bridging fibrosis or cirrhosis is noted when present- may preclude transplant

30-40% large droplet steatosis; portal and periportal fibrosis, possible bridging

30-40% large droplet steatosis Portal inflammation- moderate

Other Significant necrosis Presence of tumor Granulomata